As part of a Marie-Curie Doctoral Network (ELEVATE), we are offering a PhD student position. The proposed project sits at the interface of computational neuroscience and neuromorphic engineering, and is embedded within a strong network of European academic and industrial partners.

Host

Inês Ramos, PhD, Tissue Immunity Lab

Venue

Seminar Room

The delegation was composed of Maria Würth, granddaughter of Prof. Reinhold Würth and Executive Vice President of the Würth Group for Arts and Culture, accompanied by her husband, who met with the Champalimaud Foundation’s leadership and the directors of the clinical and scientific teams to review progress and discuss next steps for this long‑term collaboration.

The Principal Investigator’s Office is a space where ideas are challenged, discoveries take shape and research moves forward.

Here, researchers get together to discuss projects, share findings and debate scientific publications. It is a space for mentoring, project management and learning – where emerging questions spark new possibilities.

Through dialogue, critical thinking and collaboration, individual efforts become collective progress.

The initiative aims to strengthen health literacy through accessible, educational content based on the best available scientific evidence.

Developed through a partnership between the Champalimaud Foundation and the Faculdade de Medicina da Universidade de Lisboa (FMUL), the programme supports the career development of surgeons and clinician-scientists committed to advancing cancer research. The PhD degree is granted by FMUL within the framework of the Lisbon Academic Medical Centre PhD Programme.

A study just published in the prestigious Journal of Clinical Oncology definitively establishes the introduction of low-dose Tamoxifen into clinical practice as post-surgical therapy for the prevention of ductal carcinoma in situ (DCIS), the initial non-invasive form that accounts for around 25% of all breast cancers diagnosed through mammographic screening.

Redefining brain and mental health care through neurotechnologies – from Alzheimer’s to stroke, from Obsessive Compulsive Disorder to depression –, is the declared goal of the new Digital Neurotherapeutics Centre (DNTx), which opened its doors to the public at the Champalimaud Foundation (CF) on May 18th.